Fosavance 70mg/5600 IU Tablet
Marketer
MSD Pharmaceuticals Pvt Ltd
Salt Composition
Alendronic Acid (70mg) + Vitamin D3 (5600IU)
Overview Fosavance 70mg/5600 IU Tablet
Alendronate/colecalciferol 70 mg/5600 IU tablets are indicated for osteoporosis management. This medication inhibits bone density reduction, promoting bone tissue regeneration. It also contributes to improved muscle strength for enhanced bodily support. Specifically formulated for postmenopausal women, it combats bone loss through restorative processes. Optimal absorption occurs on an empty stomach; consistent daily dosing at the same time improves adherence. Full therapeutic effects may take several days to manifest. Discontinuation should only occur under physician guidance. This medication often complements a comprehensive treatment plan, potentially incorporating dietary adjustments and supplementary medications or vitamins. Common, generally mild and self-limiting, adverse effects include headache, backache, musculoskeletal discomfort, dyspepsia, heartburn, and diarrhea. Persistent or worsening symptoms warrant medical attention; your doctor can advise on mitigation strategies. Pre-existing medical conditions and all concurrent medications should be disclosed to your physician prior to commencing treatment. Regular monitoring of renal function and mineral levels may be necessary. Excessive alcohol consumption, known to impair bone health, should be avoided. Consult your doctor before using this medication if you are pregnant or breastfeeding.
Uses of Fosavance 70mg/5600 IU Tablet
Bone fragility
Major Benefits of Fosavance 70mg/5600 IU Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 70 mg/5600 IU Fosavance tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Fosavance 70mg/5600 IU Tablet:
- Headache
- Musculoskeletal (bone, muscle or joint) pain
- Back pain
- Indigestion
- Diarrhea
- Heartburn
How to use Fosavance 70mg/5600 IU Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Fosavance 70 mg/5600 IU tablet whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
How Fosavance 70mg/5600 IU Tablet works:
Osteoporosis is treated with Fosavance 70 mg/5600 IU tablets, a dual-action formulation combining alendronic acid and vitamin D3. Alendronic acid, a bisphosphonate, inhibits osteoclast activity, the bone-resorbing cells. This bone-protective action reduces fracture risk. Vitamin D3 further safeguards bone health by enhancing calcium uptake and supporting the musculature crucial for fall prevention.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Fosavance 70 mg/5600 IU Tablets. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Fosavance 70 mg/5600 IU tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Using Fosavance 70 mg/5600 IU tablets while breastfeeding appears to be safe. Available data from humans indicates minimal risk to the infant. However, for infants of breastfeeding mothers using Fosavance 70 mg/5600 IU tablets, calcium levels should be monitored for the first two months.
DrivingUNSAFE
Taking a Fosavance 70 mg/5600 IU tablet might lead to adverse reactions that could impair your driving ability. While generally not anticipated, dizziness, intense musculoskeletal pain, and ocular inflammation may occur infrequently. These potential side effects could compromise safe driving.
KidneySAFE IF PRESCRIBED
Use of the 70 mg/5600 IU Fosavance tablet in patients with kidney disease appears safe, based on currently available, albeit limited, evidence. Dose modification for these patients may not be necessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Fosavance 70 mg/5600 IU tablets in patients with liver disease appears to be safe. Existing evidence indicates dose modification may not be necessary, but physician consultation is recommended.
What if you forget to take Fosavance 70mg/5600 IU Tablet :
Should you forget to take a 70 mg/5600 IU Fosavance tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Fosavance 70mg/5600 IU Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently